PlexusDx offers the Precision Peptide Genetic Test to explore GLP-1 pathway predispositions, supporting provider conversations about personalized medication selectionthough genetic data complements, not replaces, clinical judgment
Semaglutide and other GLP-1 medications are typically considered for individuals who: Have struggled to lose weight through diet and exercise alone Are committed to making sustainable lifestyle changes Are seeking to improve metabolic health under medical guidance Are overweight and have weight-related health conditions Have obesity Have a body mass index (BMI) of 30 or higher GLP-1 Weight Loss: What to Expect As with any medication, the effect of GLP-1 medication varies from patient to patient
Sjholm , Bennet L, Nilsson PM (2025) Cognitive dysfunction in diabetesthe forgotten diabetes complication: a narrative review
Stopping cold turkey typically leads to rapid appetite return and significant weight regain within months
Obesity is a chronic disease, and it requires chronic management." The biology that drives weight gain in the first place doesnt disappear, he explained it simply picks up where it left off
The thought is that the GLP-1 agonists mechanism of action can lead to pancreatic cell hyperplasia (since the GLP-1 receptors are in the islet beta cells and exocrine duct cells), leading to a back up in pressureand you got it, inflammation